Pacira Biosciences, Inc. (PCRX)
36.48
+0.02
(+0.05%)
USD |
NASDAQ |
Nov 16, 16:00
36.48
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Price to Book Value : 2.043 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 2.043 |
| November 13, 2026 | 2.042 |
| November 12, 2026 | 2.042 |
| November 11, 2026 | 2.042 |
| November 10, 2026 | 2.044 |
| November 09, 2026 | 2.042 |
| November 06, 2026 | 2.040 |
| November 05, 2026 | 2.040 |
| November 04, 2026 | 2.039 |
| November 03, 2026 | 2.038 |
| November 02, 2026 | 2.039 |
| October 30, 2026 | 2.038 |
| October 29, 2026 | 2.038 |
| October 28, 2026 | 2.038 |
| October 27, 2026 | 2.039 |
| October 26, 2026 | 2.038 |
| October 23, 2026 | 2.040 |
| October 22, 2026 | 2.035 |
| October 21, 2026 | 2.035 |
| October 20, 2026 | 2.038 |
| October 19, 2026 | 2.035 |
| October 16, 2026 | 2.035 |
| October 15, 2026 | 2.035 |
| October 14, 2026 | 2.039 |
| October 13, 2026 | 2.034 |
| Date | Value |
|---|---|
| October 12, 2026 | 2.036 |
| October 09, 2026 | 2.034 |
| October 08, 2026 | 2.038 |
| October 07, 2026 | 1.411 |
| October 06, 2026 | 1.387 |
| October 05, 2026 | 1.403 |
| October 02, 2026 | 1.412 |
| October 01, 2026 | 1.401 |
| September 30, 2026 | 1.403 |
| September 29, 2026 | 1.520 |
| September 28, 2026 | 1.505 |
| September 25, 2026 | 1.489 |
| September 24, 2026 | 1.515 |
| September 23, 2026 | 1.460 |
| September 22, 2026 | 1.464 |
| September 21, 2026 | 1.429 |
| September 18, 2026 | 1.463 |
| September 17, 2026 | 1.451 |
| September 16, 2026 | 1.476 |
| September 15, 2026 | 1.427 |
| September 14, 2026 | 1.463 |
| September 11, 2026 | 1.503 |
| September 10, 2026 | 1.491 |
| September 09, 2026 | 1.534 |
| September 08, 2026 | 1.533 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.737 |
| Organon & Co. | 3.060 |
| ANI Pharmaceuticals, Inc. | 2.548 |
| Corcept Therapeutics, Inc. | 9.080 |
| Veru, Inc. | 1.250 |
Price to Book Value Related Metrics
| PE Ratio | 39.51 |
| PS Ratio | 2.025 |
| PEG Ratio | 0.3692 |
| Price to Free Cash Flow | 8.906 |
| Price | 36.48 |
| Earnings Yield | 2.53% |
| Market Cap | 1.455B |
| PEGY Ratio | 0.3692 |
| Operating PE Ratio | 48.52 |
| Normalized PE Ratio | 43.28 |